PH18297A - 1-phenyl-2(h,3h)endolone psychotherapeutic agents - Google Patents
1-phenyl-2(h,3h)endolone psychotherapeutic agentsInfo
- Publication number
- PH18297A PH18297A PH29565A PH29565A PH18297A PH 18297 A PH18297 A PH 18297A PH 29565 A PH29565 A PH 29565A PH 29565 A PH29565 A PH 29565A PH 18297 A PH18297 A PH 18297A
- Authority
- PH
- Philippines
- Prior art keywords
- phenyl
- indolones
- treatment
- endolone
- psychotherapeutic agents
- Prior art date
Links
- XRKBWYMXJJLQTN-UHFFFAOYSA-N 1-phenyl-3-pyrrolidin-2-ylideneindol-2-one Chemical class O=C1N(C=2C=CC=CC=2)C2=CC=CC=C2C1=C1CCCN1 XRKBWYMXJJLQTN-UHFFFAOYSA-N 0.000 abstract 1
- 208000019901 Anxiety disease Diseases 0.000 abstract 1
- 230000036506 anxiety Effects 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 206010015037 epilepsy Diseases 0.000 abstract 1
- 239000003445 gaba agent Substances 0.000 abstract 1
- 239000003176 neuroleptic agent Substances 0.000 abstract 1
- 230000003389 potentiating effect Effects 0.000 abstract 1
- 201000000980 schizophrenia Diseases 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/08—Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C43/00—Ethers; Compounds having groups, groups or groups
- C07C43/02—Ethers
- C07C43/20—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring
- C07C43/225—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring containing halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
- C07D209/32—Oxygen atoms
- C07D209/34—Oxygen atoms in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
- C07D209/32—Oxygen atoms
- C07D209/38—Oxygen atoms in positions 2 and 3, e.g. isatin
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Neurology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Neurosurgery (AREA)
- Public Health (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Anesthesiology (AREA)
- Indole Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Dental Preparations (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US06/420,544 US4476307A (en) | 1982-09-20 | 1982-09-20 | Heteroylidene indolone compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PH18297A true PH18297A (en) | 1985-05-24 |
Family
ID=23666904
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PH29565A PH18297A (en) | 1982-09-20 | 1983-09-20 | 1-phenyl-2(h,3h)endolone psychotherapeutic agents |
Country Status (24)
| Country | Link |
|---|---|
| US (1) | US4476307A (en, 2012) |
| EP (1) | EP0104860B1 (en, 2012) |
| JP (1) | JPS5976058A (en, 2012) |
| KR (1) | KR860001270B1 (en, 2012) |
| AT (1) | ATE25972T1 (en, 2012) |
| AU (1) | AU543115B2 (en, 2012) |
| CA (1) | CA1194871A (en, 2012) |
| DD (1) | DD213211A5 (en, 2012) |
| DE (1) | DE3370325D1 (en, 2012) |
| DK (1) | DK157010C (en, 2012) |
| ES (3) | ES525737A0 (en, 2012) |
| FI (1) | FI77446C (en, 2012) |
| GR (1) | GR79732B (en, 2012) |
| HU (1) | HU189747B (en, 2012) |
| IE (1) | IE55923B1 (en, 2012) |
| IL (1) | IL69758A (en, 2012) |
| NO (1) | NO161557C (en, 2012) |
| NZ (1) | NZ205638A (en, 2012) |
| PH (1) | PH18297A (en, 2012) |
| PL (3) | PL141370B1 (en, 2012) |
| PT (1) | PT77360B (en, 2012) |
| SU (1) | SU1272983A3 (en, 2012) |
| YU (4) | YU189283A (en, 2012) |
| ZA (1) | ZA836933B (en, 2012) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4879391A (en) * | 1982-09-20 | 1989-11-07 | Pfizer Inc. | 1-Phenyl-2(1H,3H)-indolone psychotherapeutic agents |
| US4760083A (en) * | 1986-04-10 | 1988-07-26 | E. I. Dupont De Nemours & Company | 3,3-disubstituted indolines |
| US5128352A (en) * | 1989-01-10 | 1992-07-07 | Pfizer Inc. | Anti-inflammatory 1-heteroaryl-oxindole-3-carboxamides |
| US5078756A (en) * | 1990-01-12 | 1992-01-07 | Major Thomas O | Apparatus and method for purification and recovery of refrigerant |
| US5158969A (en) * | 1991-08-21 | 1992-10-27 | Neurosearch A/S | Indole derivatives as potassium channel blockers |
| US5760250A (en) * | 1991-11-05 | 1998-06-02 | Zeneca Limited | Process for the preparation of 3-(α-methoxy)methylenebenzofuranones and intermediates therefor |
| DE19949209A1 (de) * | 1999-10-13 | 2001-04-19 | Boehringer Ingelheim Pharma | In 5-Stellung substituierte Indolinone, ihre Herstellung und ihre Verwendung als Arzneimittel |
| US6765012B2 (en) * | 2001-09-27 | 2004-07-20 | Allergan, Inc. | 3-(Arylamino)methylene-1,3-dihydro-2H-indol-2-ones as kinase inhibitors |
| US20050101788A1 (en) * | 2002-03-27 | 2005-05-12 | Jacopo Zanon | Method for manufacture of sertindole |
| FR2847811B1 (fr) * | 2002-11-29 | 2005-01-07 | Oreal | Composition filtrante contenant au moins un derive du dibenzoylmethane et au moins un derive de 3-(2-azacycloalkylidene)-1,3-dihydro-indol-2-one;procede de photostabilisation |
| FR2847813A1 (fr) * | 2002-11-29 | 2004-06-04 | Oreal | Compositions cosmetiques photoprotectrices contenant des derives de 3-(2-azacycloalkylidene)-1,3-dihydro-indol-2-one et utilisations |
| MX2007014114A (es) | 2005-05-10 | 2008-03-14 | Intermune Inc | Derivados de piridona para modular el sistema de proteina cinasa activada por estres. |
| CN102099036B (zh) | 2008-06-03 | 2015-05-27 | 英特芒尼公司 | 用于治疗炎性疾患和纤维化疾患的化合物和方法 |
| KR20130136591A (ko) | 2008-12-19 | 2013-12-12 | 닛뽕소다 가부시키가이샤 | １-헤테로디엔 유도체 및 유해 생물 방제제 |
| ES2471392T3 (es) | 2009-11-12 | 2014-06-26 | Nippon Soda Co., Ltd. | Derivado de 1-heterodieno y agente de control de plagas |
| AR092742A1 (es) | 2012-10-02 | 2015-04-29 | Intermune Inc | Piridinonas antifibroticas |
| CA2891122C (en) | 2012-11-14 | 2021-07-20 | The Johns Hopkins University | Methods and compositions for treating schizophrenia |
| CN110452216B (zh) | 2014-04-02 | 2022-08-26 | 英特穆恩公司 | 抗纤维化吡啶酮类 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3506683A (en) * | 1963-10-07 | 1970-04-14 | Upjohn Co | 3-(2-pyrrolidinylidene)-3h-indoles |
| GB1237008A (en) * | 1968-12-18 | 1971-06-30 | Pfizer Ltd | Novel indoline derivatives |
| US3723457A (en) * | 1969-09-30 | 1973-03-27 | Eisai Co Ltd | Indoline-2-one derivatives and preparation thereof |
| GB1374414A (en) * | 1972-06-12 | 1974-11-20 | Sterling Drug Inc | 1-acyl-3-amino-alkyl-indoles and their preparation |
| DE2557342A1 (de) * | 1975-12-19 | 1977-06-30 | Hoechst Ag | Basisch substituierte indolderivate und verfahren zu ihrer herstellung |
-
1982
- 1982-09-20 US US06/420,544 patent/US4476307A/en not_active Expired - Fee Related
-
1983
- 1983-09-16 CA CA000436845A patent/CA1194871A/en not_active Expired
- 1983-09-18 IL IL69758A patent/IL69758A/xx unknown
- 1983-09-19 DK DK425383A patent/DK157010C/da not_active IP Right Cessation
- 1983-09-19 KR KR1019830004396A patent/KR860001270B1/ko not_active Expired
- 1983-09-19 PT PT77360A patent/PT77360B/pt not_active IP Right Cessation
- 1983-09-19 ES ES525737A patent/ES525737A0/es active Granted
- 1983-09-19 NZ NZ205638A patent/NZ205638A/en unknown
- 1983-09-19 HU HU833235A patent/HU189747B/hu unknown
- 1983-09-19 FI FI833335A patent/FI77446C/fi not_active IP Right Cessation
- 1983-09-19 AT AT83305484T patent/ATE25972T1/de not_active IP Right Cessation
- 1983-09-19 NO NO833367A patent/NO161557C/no unknown
- 1983-09-19 EP EP83305484A patent/EP0104860B1/en not_active Expired
- 1983-09-19 SU SU833646758A patent/SU1272983A3/ru active
- 1983-09-19 AU AU19252/83A patent/AU543115B2/en not_active Ceased
- 1983-09-19 GR GR72470A patent/GR79732B/el unknown
- 1983-09-19 IE IE2193/83A patent/IE55923B1/en not_active IP Right Cessation
- 1983-09-19 DE DE8383305484T patent/DE3370325D1/de not_active Expired
- 1983-09-19 DD DD83254923A patent/DD213211A5/de unknown
- 1983-09-19 ZA ZA836933A patent/ZA836933B/xx unknown
- 1983-09-20 JP JP58174025A patent/JPS5976058A/ja active Granted
- 1983-09-20 PH PH29565A patent/PH18297A/en unknown
- 1983-09-20 PL PL1983250768A patent/PL141370B1/pl unknown
- 1983-09-20 YU YU01892/83A patent/YU189283A/xx unknown
- 1983-09-20 PL PL1983243826A patent/PL141609B1/pl unknown
- 1983-09-20 PL PL1983250769A patent/PL141876B1/pl unknown
-
1984
- 1984-04-25 ES ES531907A patent/ES531907A0/es active Granted
- 1984-04-25 ES ES531908A patent/ES8505951A1/es not_active Expired
-
1986
- 1986-10-01 YU YU01691/86A patent/YU169186A/xx unknown
- 1986-10-01 YU YU01693/86A patent/YU169386A/xx unknown
- 1986-10-01 YU YU01692/86A patent/YU169286A/xx unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PH18297A (en) | 1-phenyl-2(h,3h)endolone psychotherapeutic agents | |
| FI932032A0 (fi) | Kinazolinderivat foer oekande av antitumoeraktivitet | |
| GB9503601D0 (en) | Method of treatment and method of manufacture of medicament | |
| DE69111791D1 (de) | Zwischenübertragungsverfahren und rolle für die übertragung. | |
| YU1097A (sh) | 2-okso i 2-tio-1,2-dihidrohinolinil-oksazolidinoni | |
| MY130110A (en) | 6-substituted mycophenolic acid and derivatives | |
| GR3035682T3 (en) | Non-glycosylated fgf-4 and compositions containing the same. | |
| DE3889974D1 (de) | Pyrazol-Derivate und diese enthaltende Behandlungsmittel für cerebrovaskulare Krankheiten. | |
| DE69034209D1 (de) | 2'-deoxy-4'-thioribonucleoside als antivirale und antikrebsmittel | |
| ATE20519T1 (de) | Zellgiftiges arzneimittel enthaltend mindestens ein immunotoxin und chloroquin. | |
| FR2708610B1 (fr) | Dérivés du carboxyméthylidènecycloheptimidazole, méthode pour leur fabrication et agents thérapeutiques les contenant. | |
| DE69104363D1 (de) | Vinylsulfonyl pristinamycine und deren herstellung. | |
| DK0833638T3 (da) | Anvendelse af imidazo[1,5-a]quinoloner som neuroprotektive midler | |
| IT8921745A0 (it) | Sussidio didattico interattivo per lo studio e l'apprendimento di nozioni geo politiche e storiche, lingue e simili. | |
| ES510231A0 (es) | "mejoras introducidas en el objeto de la patente principal n 499.085, por maquina desrabadora de aceitunas". | |
| ITMO940015V0 (it) | Leggio modulare per la consultazione di cataloghi e simili da parte dipiu' utenti contemporaneamente. | |
| IT1263076B (it) | Uso orale e topico della n-acetil-5-metossitriptamina (melatonina) nella terapia della psoriasi volgare. |